CCR4 and neoplasm: CCR4 could enhance anti-tumor immunity, mainly by targeting and blocking the infiltration of regulatory T cells (Tregs)into the tumor microenvironment and inhibiting the stability of the TIL-Treg pool (Gao et al., 2022).